Amgen Shares May Be 49% Undervalued According to DCF Model

miércoles, 14 de enero de 2026, 7:17 am ET1 min de lectura
AMGN--

Amgen Inc. (NASDAQ:AMGN) shares could be 49% undervalued based on a 2-stage free cash flow to equity model, with a fair value estimate of US$637. The current share price of US$324 suggests that the company is potentially undervalued. The analyst price target of US$332 is 92% lower than the fair value estimate.

Amgen Shares May Be 49% Undervalued According to DCF Model

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios